{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:33:27Z","timestamp":1792460007340,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00210-025-04713-8","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:01:55Z","timestamp":1777500115000},"page":"15571-15586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Resveratrol inhibits aerobic glycolysis and promotes cuproptosis in acute myeloid leukemia via the PI3K\/AKT signaling pathway"],"prefix":"10.1007","volume":"399","author":[{"given":"Cheng","family":"Lian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingchong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"4713_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27092665","volume":"27","author":"SA Almatroodi","year":"2022","unstructured":"Almatroodi SA, Alsahli AM, Aljohani SMA, Alhumaydhi FA, Babiker AY, Khan AA, Rahmani AH (2022) Potential therapeutic targets of resveratrol, a plant polyphenol, and its role in the therapy of various types of cancer. Molecules 27:2665","journal-title":"Molecules"},{"key":"4713_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112913","volume":"10","author":"R Alvarez","year":"2021","unstructured":"Alvarez R, Mandal D, Chittiboina P (2021) Canonical and non-canonical roles of PFKFB3 in brain tumors. Cells 10:2913","journal-title":"Cells"},{"key":"4713_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063142","volume":"25","author":"I Barba","year":"2024","unstructured":"Barba I, Carrillo-Bosch L, Seoane J (2024) Targeting the Warburg effect in cancer: where do we stand? Int J Mol Sci 25:3142","journal-title":"Int J Mol Sci"},{"key":"4713_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02801-w","volume":"22","author":"P Bouchalova","year":"2022","unstructured":"Bouchalova P, Bouchal P (2022) Current methods for studying metastatic potential of tumor cells. Cancer Cell Int 22:394","journal-title":"Cancer Cell Int"},{"key":"4713_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS (2020) Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol 17:395\u2013417","journal-title":"Nat Rev Clin Oncol"},{"key":"4713_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10060966","volume":"10","author":"F Cascardo","year":"2021","unstructured":"Cascardo F, Anselmino N, P\u00e1ez A, Labanca E, Sanchis P, Antico-Arciuch V, Navone N, Gueron G, V\u00e1zquez E, Cotignola J (2021) Ho-1 modulates aerobic glycolysis through LDH in prostate cancer cells. Antioxidants 10:966","journal-title":"Antioxidants"},{"key":"4713_CR7","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","volume":"401","author":"CD DiNardo","year":"2023","unstructured":"DiNardo CD, Erba HP, Freeman SD, Wei AH (2023) Acute myeloid leukaemia. Lancet 401:2073\u20132086","journal-title":"Lancet"},{"key":"4713_CR8","doi-asserted-by":"crossref","unstructured":"Dreishpoon MB, Bick NR, Petrova B, Warui DM, Cameron A, Booker SJ, Kanarek N, Golub TR, Tsvetkov P (2023) FDX1 regulates cellular protein lipoylation through direct binding to LIAS. bioRxiv","DOI":"10.1101\/2023.02.03.526472"},{"key":"4713_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1182\/blood.2021014670","volume":"141","author":"A Ediriwickrema","year":"2023","unstructured":"Ediriwickrema A, Gentles AJ, Majeti R (2023) Single-cell genomics in AML: extending the frontiers of AML research. Blood 141:345\u2013355","journal-title":"Blood"},{"key":"4713_CR10","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.tips.2024.03.005","volume":"45","author":"M Forsberg","year":"2024","unstructured":"Forsberg M, Konopleva M (2024) AML treatment: conventional chemotherapy and emerging novel agents. Trends Pharmacol Sci 45:430\u2013448","journal-title":"Trends Pharmacol Sci"},{"key":"4713_CR11","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10495-021-01689-7","volume":"26","author":"X Fu","year":"2021","unstructured":"Fu X, Li M, Tang C, Huang Z, Najafi M (2021) Targeting of cancer cell death mechanisms by resveratrol: a review. Apoptosis 26:561\u2013573","journal-title":"Apoptosis"},{"key":"4713_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.760055","volume":"12","author":"M Gao","year":"2021","unstructured":"Gao M, Yang J, Gong H, Lin Y, Liu J (2021) Trametinib inhibits the growth and aerobic glycolysis of glioma cells by targeting the PKM2\/c-Myc axis. Front Pharmacol 12:760055","journal-title":"Front Pharmacol"},{"key":"4713_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07613-0","volume":"16","author":"Y Gu","year":"2025","unstructured":"Gu Y, Wang H, Xue W, Zhu L, Fu C, Zhang W, Mu G, Xia Y, Wei K, Wang J (2025) Endoplasmic reticulum stress related super-enhancers suppress cuproptosis via glycolysis reprogramming in lung adenocarcinoma. Cell Death Dis 16:316","journal-title":"Cell Death Dis"},{"key":"4713_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B (2021) Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther 6:425","journal-title":"Signal Transduct Target Ther"},{"key":"4713_CR15","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S290731","author":"Y Hu","year":"2021","unstructured":"Hu Y, Zhang K, Zhu X, Zheng X, Wang C, Niu X, Jiang T, Ji X, Zhao W, Pang L (2021) Synergistic inhibition of drug-resistant colon cancer growth with PI3K\/mTOR dual inhibitor BEZ235 and nano-emulsioned paclitaxel via reducing multidrug resistance and promoting apoptosis. Int J Nanomedicine. https:\/\/doi.org\/10.2147\/IJN.S290731","journal-title":"Int J Nanomedicine"},{"key":"4713_CR16","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.3390\/cimb45040222","volume":"45","author":"Y-K Huang","year":"2023","unstructured":"Huang Y-K, Chang K-C, Li C-Y, Lieu A-S, Lin C-L (2023) AKR1B1 represses glioma cell proliferation through p38 MAPK-mediated Bcl-2\/BAX\/Caspase-3 apoptotic signaling pathways. Curr Issues Mol Biol 45:3391\u20133405","journal-title":"Curr Issues Mol Biol"},{"key":"4713_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232213689","volume":"23","author":"JY Jang","year":"2022","unstructured":"Jang JY, Im E, Kim ND (2022) Mechanism of resveratrol-induced programmed cell death and new drug discovery against cancer: a review. Int J Mol Sci 23:13689","journal-title":"Int J Mol Sci"},{"key":"4713_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117415","volume":"179","author":"Y Jin","year":"2024","unstructured":"Jin Y, Wu Q, Pan S, Zhou Q, Liu H, Zhang Q, Zhang J, Zhu X (2024) Baicalein enhances cisplatin sensitivity in cervical cancer cells by promoting cuproptosis through the Akt pathway. Biomed Pharmacother 179:117415","journal-title":"Biomed Pharmacother"},{"key":"4713_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03698-x","volume":"25","author":"B Jin","year":"2025","unstructured":"Jin B, Miao Z, Pan J, Zhang Z, Yang Y, Zhou Y, Jin Y, Niu Z, Xu Q (2025) The emerging role of glycolysis and immune evasion in ovarian cancer. Cancer Cell Int 25:78","journal-title":"Cancer Cell Int"},{"key":"4713_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodhyd.2020.106291","volume":"112","author":"M Jo","year":"2021","unstructured":"Jo M, Ban C, Goh KK, Choi YJ (2021) Enhancement of the gut-retention time of resveratrol using waxy maize starch nanocrystal-stabilized and chitosan-coated Pickering emulsions. Food Hydrocolloids 112:106291","journal-title":"Food Hydrocolloids"},{"key":"4713_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2022.104787","volume":"127","author":"MR Khezri","year":"2022","unstructured":"Khezri MR, Jafari R, Yousefi K, Zolbanin NM (2022) The PI3K\/AKT signaling pathway in cancer: molecular mechanisms and possible therapeutic interventions. Exp Mol Pathol 127:104787","journal-title":"Exp Mol Pathol"},{"key":"4713_CR22","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1007\/s10528-023-10473-y","volume":"62","author":"Y Li","year":"2024","unstructured":"Li Y, Kan X (2024) Cuproptosis-related genes MTF1 and LIPT1 as novel prognostic biomarker in acute myeloid leukemia. Biochem Genet 62:1136\u20131159","journal-title":"Biochem Genet"},{"key":"4713_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010026","volume":"15","author":"L Li","year":"2022","unstructured":"Li L, Wang S, Zhou W (2022) Balance cell apoptosis and pyroptosis of caspase-3-activating chemotherapy for better antitumor therapy. Cancers 15:26","journal-title":"Cancers"},{"key":"4713_CR24","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2023.5532","volume":"63","author":"Z Li","year":"2023","unstructured":"Li Z, Jiang Y, Liu J, Fu H, Yang Q, Song W, Li Y (2023) Exosomes from PYCR1 knockdown bone marrow mesenchymal stem inhibits aerobic glycolysis and the growth of bladder cancer cells via regulation of the EGFR\/PI3K\/AKT pathway. Int J Oncol 63:84","journal-title":"Int J Oncol"},{"key":"4713_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01062-w","volume":"14","author":"H Liu","year":"2021","unstructured":"Liu H (2021) Emerging agents and regimens for AML. J Hematol Oncol 14:49","journal-title":"J Hematol Oncol"},{"key":"4713_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2021.112664","volume":"224","author":"J Liu","year":"2021","unstructured":"Liu J, Feng R, Wang D, Huo T, Jiang H (2021) Triclosan-induced glycolysis drives inflammatory activation in microglia via the Akt\/mTOR\/HIF 1\u03b1 signaling pathway. Ecotoxicol Environ Saf 224:112664","journal-title":"Ecotoxicol Environ Saf"},{"key":"4713_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-01095-1","volume":"8","author":"Y-R Liu","year":"2022","unstructured":"Liu Y-R, Song D-D, Liang D-M, Li Y-J, Yan Y-F, Sun H-F, Zhang M-L, Hu J-X, Zhao Y-L, Liang Y (2022) Oncogenic TRIB2 interacts with and regulates PKM2 to promote aerobic glycolysis and lung cancer cell procession. Cell Death Discov 8:306","journal-title":"Cell Death Discov"},{"key":"4713_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2022.155691","volume":"836","author":"Q Lou","year":"2022","unstructured":"Lou Q, Zhang M, Zhang K, Liu X, Zhang Z, Zhang X, Yang Y, Gao Y (2022) Arsenic exposure elevated ROS promotes energy metabolic reprogramming with enhanced AKT-dependent HK2 expression. Sci Total Environ 836:155691","journal-title":"Sci Total Environ"},{"key":"4713_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12030592","volume":"12","author":"A Majumdar","year":"2023","unstructured":"Majumdar A, Shah MR, Park JJ, Narayanan N, Kaye KS, Bhatt PJ (2023) Challenges and opportunities in antimicrobial stewardship among hematopoietic stem cell transplant and oncology patients. Antibiotics 12:592","journal-title":"Antibiotics"},{"key":"4713_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26010229","volume":"26","author":"T Meng","year":"2021","unstructured":"Meng T, Xiao D, Muhammed A, Deng J, Chen L, He J (2021) Anti-inflammatory action and mechanisms of resveratrol. Molecules 26:229","journal-title":"Molecules"},{"key":"4713_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s40104-022-00822-z","volume":"14","author":"Q Meng","year":"2023","unstructured":"Meng Q, Li J, Wang C, Shan A (2023) Biological function of resveratrol and its application in animal production: a review. J Anim Sci Biotechnol 14:25","journal-title":"J Anim Sci Biotechnol"},{"key":"4713_CR32","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1182\/blood.2022018092","volume":"141","author":"SK Mishra","year":"2023","unstructured":"Mishra SK, Millman SE, Zhang L (2023) Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targets. Blood 141:1119\u20131135","journal-title":"Blood"},{"key":"4713_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2023.2196482","volume":"28","author":"MZ Mohamed Jiffry","year":"2023","unstructured":"Mohamed Jiffry MZ, Kloss R, Ahmed-Khan M, Carmona-Pires F, Okam N, Weeraddana P, Dharmaratna D, Dandwani M, Moin K (2023) A review of treatment options employed in relapsed\/refractory AML. Hematology 28:2196482","journal-title":"Hematology"},{"key":"4713_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.896426","volume":"12","author":"J Niu","year":"2022","unstructured":"Niu J, Peng D, Liu L (2022) Drug resistance mechanisms of acute myeloid leukemia stem cells. Front Oncol 12:896426","journal-title":"Front Oncol"},{"key":"4713_CR35","doi-asserted-by":"crossref","unstructured":"Paul S, Ghosh S, Kumar S (2022) Tumor glycolysis, an essential sweet tooth of tumor cells, Seminars in cancer biology. Elsevier, pp. 1216\u20131230","DOI":"10.1016\/j.semcancer.2022.09.007"},{"key":"4713_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.819128","volume":"12","author":"Y Peng","year":"2022","unstructured":"Peng Y, Wang Y, Zhou C, Mei W, Zeng C (2022) PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: are we making headway? Front Oncol 12:819128","journal-title":"Front Oncol"},{"key":"4713_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41423-021-00727-3","volume":"19","author":"BI Reinfeld","year":"2022","unstructured":"Reinfeld BI, Rathmell WK, Kim TK, Rathmell JC (2022) The therapeutic implications of immunosuppressive tumor aerobic glycolysis. Cell Mol Immunol 19:46\u201358","journal-title":"Cell Mol Immunol"},{"key":"4713_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.63623\/9k14tf70","volume":"1","author":"J Ren","year":"2024","unstructured":"Ren J (2024) Advances in combination therapy for gastric cancer: integrating targeted agents and immunotherapy. Adv Clin Pharmacol Ther 1:1\u201315","journal-title":"Adv Clin Pharmacol Ther"},{"key":"4713_CR39","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.2174\/1381612828666220705113514","volume":"28","author":"Z Saleem","year":"2022","unstructured":"Saleem Z, Rehman K, Hamid Akash MS (2022) Role of drug delivery system in improving the bioavailability of resveratrol. Curr Pharm Des 28:1632\u20131642","journal-title":"Curr Pharm Des"},{"key":"4713_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12010072","volume":"12","author":"A Schurr","year":"2022","unstructured":"Schurr A, Passarella S (2022) Aerobic glycolysis: a deoxymoron of (neuro) biology. Metabolites 12:72","journal-title":"Metabolites"},{"key":"4713_CR41","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.1007\/s12010-023-04511-z","volume":"195","author":"H Shao","year":"2023","unstructured":"Shao H, Chen J, Li A, Ma L, Tang Y, Chen H, Chen Y, Liu J (2023) Salvigenin suppresses hepatocellular carcinoma glycolysis and chemoresistance through inactivating the PI3K\/AKT\/GSK-3\u03b2 pathway. Appl Biochem Biotechnol 195:5217\u20135237","journal-title":"Appl Biochem Biotechnol"},{"key":"4713_CR42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0140-6736(18)31041-9","volume":"392","author":"NJ Short","year":"2018","unstructured":"Short NJ, Rytting ME, Cortes JE (2018) Acute myeloid leukaemia. Lancet 392:593\u2013606","journal-title":"Lancet"},{"key":"4713_CR43","doi-asserted-by":"publisher","first-page":"10286","DOI":"10.1039\/D3FO03065B","volume":"14","author":"PM Silva","year":"2023","unstructured":"Silva PM, Gon\u00e7alves C, Pastrana LM, Coimbra MA, Vicente AA, Cerqueira MA (2023) Recent advances in oral delivery systems of resveratrol: foreseeing their use in functional foods. Food Funct 14:10286\u201310313","journal-title":"Food Funct"},{"key":"4713_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15102758","volume":"15","author":"B Song","year":"2023","unstructured":"Song B, Wang W, Tang X, Goh RMW-J, Thuya WL, Ho PCL, Chen L, Wang L (2023) Inhibitory potential of resveratrol in cancer metastasis: from biology to therapy. Cancers (Basel) 15:2758","journal-title":"Cancers (Basel)"},{"key":"4713_CR45","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3324\/haematol.2022.280800","volume":"108","author":"P Stelmach","year":"2023","unstructured":"Stelmach P, Trumpp A (2023) Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica 108:353\u2013366","journal-title":"Haematologica"},{"key":"4713_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032652","volume":"24","author":"L-Y Tian","year":"2023","unstructured":"Tian L-Y, Smit DJ, J\u00fccker M (2023) The role of PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma metabolism. Int J Mol Sci 24:2652","journal-title":"Int J Mol Sci"},{"key":"4713_CR47","doi-asserted-by":"crossref","unstructured":"Tokaz MC, Baldomero H, Cowan AJ, Saber W, Greinix H, Koh MB, Kr\u00f6ger N, Mohty M, Galeano S, Okamoto, S (2023) An analysis of the worldwide utilization of hematopoietic stem cell transplantation for acute myeloid leukemia. Transpl Cellular Therapy 29:279. e271\u2013279. e210","DOI":"10.1016\/j.jtct.2022.12.013"},{"key":"4713_CR48","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, Rossen J, Joesch-Cohen L, Humeidi R, Spangler RD (2022) Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375:1254\u20131261","journal-title":"Science"},{"key":"4713_CR49","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1038\/s41418-021-00823-x","volume":"28","author":"S Uxa","year":"2021","unstructured":"Uxa S, Castillo-Binder P, Kohler R, Stangner K, M\u00fcller GA, Engeland K (2021) Ki-67 gene expression. Cell Death Differ 28:3357\u20133370","journal-title":"Cell Death Differ"},{"key":"4713_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215557","volume":"13","author":"A Vall\u00e9e","year":"2021","unstructured":"Vall\u00e9e A, Lecarpentier Y, Vall\u00e9e J-N (2021) The key role of the WNT\/\u03b2-catenin pathway in metabolic reprogramming in cancers under normoxic conditions. Cancers 13:5557","journal-title":"Cancers"},{"key":"4713_CR51","doi-asserted-by":"crossref","unstructured":"Wang S, Sun Z, Lei Z, Zhang H-T (2022a) RNA-binding proteins and cancer metastasis. Seminars in cancer biology. Elsevier, pp. 748\u2013768","DOI":"10.1016\/j.semcancer.2022.03.018"},{"key":"4713_CR52","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41423-022-00866-1","volume":"19","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang L, Zhou F (2022b) Cuproptosis: a new form of programmed cell death. Cell Mol Immunol 19:867\u2013868","journal-title":"Cell Mol Immunol"},{"key":"4713_CR53","doi-asserted-by":"publisher","first-page":"13509","DOI":"10.1021\/acsami.3c17792","volume":"16","author":"Q Wang","year":"2024","unstructured":"Wang Q, Huang CH, Wibowo FS, Amin R, Shen J, Li F, Babu RJ (2024) Elesclomol-copper nanoparticles overcome multidrug resistance in cancer cells. ACS Appl Mater Interfaces 16:13509\u201313524","journal-title":"ACS Appl Mater Interfaces"},{"key":"4713_CR54","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jdermsci.2021.07.010","volume":"103","author":"Z Wei","year":"2021","unstructured":"Wei Z, Chen G, Hu T, Mo X, Hou X, Cao K, Wang L, Pan Z, Wu Q, Li X (2021) Resveratrol ameliorates lipid accumulation and inflammation in human SZ95 sebocytes via the AMPK signaling pathways in vitro. J Dermatol Sci 103:156\u2013166","journal-title":"J Dermatol Sci"},{"key":"4713_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03497-2","volume":"20","author":"W Wei","year":"2022","unstructured":"Wei W, Huang S, Ling Q, Mao S, Qian Y, Ye W, Li F, Pan J, Lin X, Huang J (2022) Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia. J Transl Med 20:299","journal-title":"J Transl Med"},{"issue":"1580\u20131596","key":"4713_CR56","volume":"35","author":"L Wu","year":"2023","unstructured":"Wu L, Jin Y, Zhao X, Tang K, Zhao Y, Tong L, Yu X, Xiong K, Luo C, Zhu J (2023) Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1. Cell Metab 35(1580\u20131596):e1589","journal-title":"Cell Metab"},{"key":"4713_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-64981-x","volume":"14","author":"S Yang","year":"2024","unstructured":"Yang S, Li X, Yan J, Jiang F, Fan X, Jin J, Zhang W, Zhong D, Li G (2024a) Disulfiram downregulates ferredoxin 1 to maintain copper homeostasis and inhibit inflammation in cerebral ischemia\/reperfusion injury. Sci Rep 14:15175","journal-title":"Sci Rep"},{"key":"4713_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e35721","author":"Y Yang","year":"2024","unstructured":"Yang Y, Pu J, Yang Y (2024b) Glycolysis and chemoresistance in acute myeloid leukemia. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35721","journal-title":"Heliyon"},{"key":"4713_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1460987","volume":"11","author":"L Zhang","year":"2024","unstructured":"Zhang L, Deng R, Guo R, Jiang Y, Guan Y, Chen C, Zhao W, Huang G, Liu L, Du H (2024) Recent progress of methods for cuproptosis detection. Front Mol Biosci 11:1460987","journal-title":"Front Mol Biosci"},{"key":"4713_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02485-0","volume":"41","author":"P Zheng","year":"2022","unstructured":"Zheng P, Zhou C, Lu L, Liu B, Ding Y (2022) Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy. J Exp Clin Cancer Res 41:271","journal-title":"J Exp Clin Cancer Res"},{"key":"4713_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-023-05148-9","volume":"24","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, He J, Li Z, Yang W (2023) Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia. BMC Bioinformatics 24:37","journal-title":"BMC Bioinformatics"},{"key":"4713_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2023.101911","volume":"69","author":"L Zou","year":"2023","unstructured":"Zou L, Fang Y, He W (2023) TRAF7 inhibits glycolysis to potentiate growth inhibition and apoptosis of myeloid leukemia cells via regulating the KLF2-PFKFB3 axis. Mol Cell Probes 69:101911","journal-title":"Mol Cell Probes"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04713-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04713-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04713-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:59:55Z","timestamp":1784775595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04713-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4713"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04713-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The manuscript has neither been previously published nor is under consideration by any other journal. The authors have all approved the content of the paper.","order":1,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}